RE:RE:RE:RE:RE:RE:HELLO ANDRE...PLEASE TELL US WE ARE INVOLVED SOMEHOW !!!ARIMA11 wrote: Great post u2bob. I was looking at https://diabetesaction.ca/our-partners/
Foundational Partners AstraZeneca
Bayer
Merck
SunLife Financial
And then this news release...
Dec. 5th 2016- BAYER Canada and DIAGNOS join efforts against Diabetes. Pilot project contract for diabetic macular edema and diabetic retinopathy screening with BAYER Canada in Toronto (1,000 patient).
Wonder if it is related...
https://diabetesaction.ca/wp-content/uploads/2016/11/DAC_newsletter_november2016_ENGLISH.pdf
Timing is interesting,
u2bob wrote: LannyMcdonald wrote: Great job on finding the article and emailing Andre. Lets hope this gets the ball rolling in Canada! Diabetes Canada seems very interested as you say, lets hope they jump on the Diagnos train, I cant see why not, why would they wait for the University to create an algorithm, when we have a perfectly fed algorithm in Diagnos, with close to half a million scans, if data is key, we have lots of it. On the other hand, the University is at least one to two years away, from where we are right now. I cant wait to see how this unfolds. Go get them Andre, send in your Pit Bull of a salesman, and don't take No for an answer! Glta.
Hi Lanny I agree Andre should have all hands on board for this ...I noticed they want to set up a mobile van ...well we have done that we also have AI CARA Platform and new Blockchian software in the works for security...Diagnos fits the bill in every aspect from what I'm seeing...here is some more ifo below that shows they want to expand across the country and all ethinic groups... Findings from this study suggest that tele-ophthalmology, using portable retinal camera, might be more cost effective way of screening for diabetic retinopathy than a standard screening in Toronto (semi) urban communities in diabetic individuals at risk for developing DR and with limited access to eye care specialists.
In collaboration with Laval University and Ottawa Health Research Institute a new research project was developed and now actively enrolling participants. Using structural interviews, the aim is to identify and understand barriers and enablers, ethnocultural minorities with the higher risk of DR (i.e. immigrants from South Asia, China and Francophone immigrants of African descent), are facing to attend DR screening in Ontario and Quebec. These results will enable the design of fit-for-purpose interventions that will specifically address the barriers experienced by these groups.
In our newest project, with the team of scientists from Women’s Collage Hospital, we are testing different strategies for scaling up the DR screening program through Family Health Teams.
Furthermore, Diabetes Action Canada and OTN are also exploring collaborations with the Canadian National Institute for the Blind (CNIB) Mobile Eye Care van. This van serves over 30 communities in Northern Ontario and provides diagnostic and intervention services in eye care, as well as education to local health professionals. By collaborating with CNIB, Diabetes Action Canada has an opportunity to advance Indigenous community-based diabetic eye services in remote and underrepresented areas. Videos on this important work can be found here featuring Diabetes Action Canada co-investigator Dr. Stephen Kosar
On the National level, Diabetes Action Canada is currently developing a Diabetes Repository using anonymized patient data collected initially from Ontario, Alberta and Quebec. This repository will allow for expanded dataset of consenting patients with diabetes in multiple provinces with the ultimate goal to engage these patients to participate in Clinical Trials and/or monitor interventions. Using this repository, our team will identify the ophthalmology imaging software interface requirements to create a backbone of retinopathy data within this database. Retinopathy data in the Diabetes Repository will be used to create a feedback loop of reports that inform and improve communication between the diabetic retinopathy screening program, patients and health care provider.
As an exciting new initiative, Diabetes Action Canada is currently exploring a collaboration investigating the role of artificial intelligence (AI) in retinal image analytics with the Montreal Institute for Learning Algorithms (MILA). Using advanced technology to reduce the burden of the human interventions needed to process retinal scan images, this AI initiative will advance the improvement of care and outcomes of those individuals living with diabetes.
Lets hope Andre and team get something done here Canada ...
Have a great weekend ...
Bob
More Questions....Who could this be below from our Nov.22 NR. ?????
Artificial Intelligence (AI), announces today a
second Cardio project with one of the largest pharmaceutical company in the world to monitor hypertensive patients under treatment
“We will provide state-of-the-art medical support and patient attention to detect and prevent blindness caused by diabetic retinopathy along with the analysis of cardiovascular risks using the same retina photograph”, said Dr. Hadi Chakor, Chief Medical Officer (CMO) of DIAGNOS.
The project will start this month, even though the
Cardio application is not fully operational. Our customer believes that we are on track to deliver a new non-invasive test that will change the healthcare future for chronic diseases through the use of retina imaging.” said Mr. Andr Larente, CEO of DIAGNOS.
If this big company is one we are working with in T.O. then can you imagine the NR...And if not they sound like they are very BIG !
Not knowing is killing us ...I'm still adding shares cause of price ...and I really do believe we will have our day sun !
Good luck
Bob